Public versus private family planning services in rural India

Public versus private family planning services in rural India

She has travelled eleven kilometres by auto-rickshaw to ask about contraception, and before I even finish taking her obstetric history, she asks the question I hear constantly in these rooms: should I get this done at the government hospital, or somewhere else? It is the question I want to pull apart in this piece, because the answer is rarely simple, and because the choice between public and private family planning services in rural India is not a binary switch but a constellation of methods, geographies, and trust pathways that the numbers we cite in conferences only ever partially capture.

The Public Sector's Hold on Permanent Methods

When I sit in our weekly case review and someone mentions female sterilization, the conversation almost always centres on a public facility. That is not anecdotal preference, it is the structural reality of rural reproductive health in India. NFHS-5, the most recent round of the National Family Health Survey covering the 2019 to 2021 period, makes clear that public health facilities remain the dominant source for female sterilization and for the bulk of long-acting methods in rural India. Government district hospitals, community health centres, and the network of Primary Health Centres form the backbone through which tubal ligation and vasectomy services reach women who, like the patient I described earlier, would otherwise have no realistic access to a trained provider.

What I appreciate about working within this system is that the public pathway is, for many women, the only financially viable route. Tubal ligation at a government facility is free, includes a small compensation package in most states under schemes linked to the national family planning mission, and is bundled with postoperative follow-up that, while imperfect, exists in a structured way. There is also a register, a name, an accountable provider, and for a woman in a remote block whose only previous contact with biomedicine may have been an auxiliary nurse midwife, that institutional continuity is not a small thing. It is the difference between feeling seen by a system and feeling like an anonymous case in someone else's quota.

But the public pathway is not frictionless. Waiting lists are real. The counselling window can feel rushed when a camp approach is used, and the consent process, while tightly regulated on paper, has historically been stretched when providers are under pressure to meet sterilisation targets. As a clinician, I have watched the system mature in this regard over the past decade, with the government actively shifting away from camp-driven numbers toward quality-adjusted indicators, but the reputational weight of older practices still sits in the room during consent conversations. It colours the question the woman in my clinic asks me, even if she cannot name what she is really asking about.

Where the Private Sector Quietly Steps In

The picture shifts the moment the conversation turns to condoms or oral contraceptive pills. Here, the private sector, meaning the chemist down the bazaar, the branded product on a kirana shelf, and to a lesser extent the private clinic, is doing a substantial amount of the work. NFHS-5 data confirms that private commercial retail networks are the more frequent source for temporary spacing methods in rural areas, particularly for pills and condoms, where convenience, anonymity, and the absence of a clinical appointment all matter enormously to the buyer.

This is the part of the family planning story that does not get enough airtime in policy circles. A woman who needs three cycles of oral contraceptives does not want to spend a day travelling to a PHC, waiting in an outpatient line, and explaining her reproductive intentions to a male compounder at the registration desk. She wants to walk to the local medical store, ask quietly, pay a small amount, and walk home. The private retail sector meets that need in a way the public system, by design, cannot, and frankly should not try to replicate.

The choice between public and private is rarely about ideology; it is about proximity, privacy, and what method a woman is actually seeking on that particular day.

The gap widens for injectables and for intrauterine systems, where both sectors have room to grow. Depot medroxyprogesterone acetate (DMPA) is available through public facilities and a growing number of private providers, but uptake remains uneven across districts and provider comfort with the method varies widely. The contraceptive implant, while present in select private tertiary settings, has a thin footprint in rural India and is essentially a non-entity in the public supply chain for most blocks. This is where I see the most uncomfortable mismatch in our hybrid delivery model: the methods that give a woman the longest protection per visit are often the least accessible at the moment she asks for them, and the ones that demand the most repeat engagement from the woman are the most easily available.

Reading the 67 Percent Story

The headline figure that surfaces in every policy brief is the jump in India's overall Contraceptive Prevalence Rate from 54 percent in NFHS-4 to 67 percent in NFHS-5. As a practitioner, I find that number both encouraging and slightly misleading in equal measure, because the rise reflects a real shift in behaviour but also a rebalancing of method mix that has implications for how we plan services across the next survey cycle.

A non-trivial portion of that growth came from increased uptake of modern methods, particularly female sterilization, which remains the single most prevalent modern method in rural India. NFHS-5 also shows a method shift toward greater reliance on pills and condoms in younger cohorts, a pattern that, from clinical experience on the ground, tracks with districts where ASHA workers have built sustained home-visit relationships over multiple years, even though the survey itself does not directly measure ASHA visit intensity. But the aggregate figure obscures a quiet but consequential change: as method mix diversifies, the service delivery burden diversifies too, and no single sector can carry it alone.

The table is a simplification, of course — the truth on the ground varies by district, by state, and by which ASHA worker happens to be on duty that week — but it captures the texture of how a rural Indian woman typically moves between these two systems over the course of her reproductive life.

The 9.4 Percent Who Are Not Yet Reached

Perhaps the most clinically meaningful figure in NFHS-5 is the one that describes who is not using contraception despite saying they want to: an unmet need for family planning of 9.4 percent. In a country of this size, that is not a rounding error, it is millions of women, and it is the figure that should keep reproductive health practitioners awake at night when we plan our next quarter.

When I think about unmet need, I think less about ideology and more about logistics. The woman with unmet need is often the woman who lives beyond the catchment of her sub-centre, who cannot afford the implicit cost of a half-day off agricultural labour, whose husband has not been brought into the conversation, or who has heard a rumour about side effects that no one in a white coat has had the chance to address. Meeting that need almost always requires a hybrid delivery model: public-sector outreach to bring her into the conversation, private-sector convenience to keep her supplied with whatever method she chooses, and a community-level intermediary, usually an ASHA, sometimes an Anganwadi worker, to hold the relationship between visits so she does not drift back out of care.

This is also where method counselling has to mature. When a woman tells me she stopped the pill because of headaches or irregular bleeding, that is not a refusal of contraception, it is a request for a different method. If the public facility cannot offer her a Copper-T insertion on a return visit because the trained provider is on leave, and the private clinic in her block is an hour away and charges a fee her family cannot absorb, she falls into the unmet need column, not because she rejected family planning but because the system did not catch her when she was ready to choose.

Regional Reality Check

It would be a mistake, and I have seen it made in advocacy documents more than once, to treat India as a single reproductive health geography. The public-private split I have described here skews heavily toward the public sector for permanent methods and toward private retail for temporary methods in most rural districts, but the magnitude of that skew shifts dramatically by state. Southern states with stronger PHC infrastructure show higher public-sector sterilisation uptake; states with active social marketing networks for condoms show higher private retail penetration for spacing methods. NFHS-5 makes plain that state-level disparities are wide enough that a national average, while useful for grant applications and donor conversations, can mislead a district-level programme officer into planning for a reality that simply does not exist on their patch.

What I tell junior colleagues who rotate through our unit is this: do not plan a service delivery strategy from a national number. Plan it from the sub-centre register, from the ASHA's door-to-door mapping, and from the conversations you have with women who have already voted with their feet about which facility they trust for which method. The 67 percent CPR is a national achievement worth acknowledging, and the 9.4 percent unmet need is a national challenge worth chasing, but the work that closes that gap is irreducibly local.

Closing the gap is not about choosing a sector. It is about weaving them together so that a woman never has to fall out of care simply because the method she needs lives in the other building.

The patient in my Maharashtra clinic that morning, by the end of our conversation, chose a Copper-T insertion at the PHC, a public-sector service that took twenty minutes and cost her nothing, with a follow-up visit already booked. Two months later, when I asked how she was managing, she told me her husband had started buying condoms from the chemist in the next village. That is the hybrid system working the way it was meant to: public infrastructure for the clinical anchor, private retail for the everyday maintenance of a reproductive choice she had made and kept. Her question that day was not which sector was better. It was which sector was right for which method, and the answer to that question is what we should be designing every rural family planning programme around.